SELL and systemic sclerosis: In contrast, decreased serum CD62L has also been reported by other studies of SSc patients [29,30], with a negative correlation between soluble CD62L and disease activity or severity of diffuse cutaneous SSc [31], and similar levels have also been observed in the SSc and HC subjects [32,33].